Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features.
about
Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell linesTumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancersDistinct epigenetic domains separated by a CTCF bound insulator between the tandem genes, BLU and RASSF1AInactivation of SLIT2-ROBO1/2 pathway in premalignant lesions of uterine cervix: clinical and prognostic significancesLow VHL mRNA expression is associated with more aggressive tumor features of papillary thyroid carcinoma.Array-CGH and breast cancer.Molecular characterization of the tumor-suppressive function of nischarin in breast cancer.Expression of integrin-binding protein Nischarin in metastatic breast cancer.Genome-Wide Loss of Heterozygosity and DNA Copy Number Aberration in HPV-Negative Oral Squamous Cell Carcinoma and Their Associations with Disease-Specific Survival.Identification of novel gene expression targets for the Ras association domain family 1 (RASSF1A) tumor suppressor gene in non-small cell lung cancer and neuroblastoma.FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma.Frequent alterations of SLIT2-ROBO1-CDC42 signalling pathway in breast cancer: clinicopathological correlation.Significance of glutathione peroxidase 1 and caudal-related homeodomain transcription factor in human gastric adenocarcinoma.Functional role of SETD2, BAP1, PARP-3 and PBRM1 candidate genes on the regulation of hTERT gene expressionLoss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancer.ZDHHC3 as a Risk and Mortality Marker for Breast Cancer in African American Women.
P2860
Q24611593-F85516B4-7C18-4457-8F6E-B51ACBA5A835Q28206723-5E107D43-8824-4CD3-9689-17CDE280EEC3Q33705017-FCE27577-8C60-49D0-AF87-37D78FEE0169Q34311871-F7317A8C-9375-4004-A12A-37CBE5E77E00Q34662980-E575DFDE-FA4D-4EE5-8C9D-AEAE4066847CQ35012854-A7FDFE5D-3115-4A13-A87C-18EF1964D773Q35383627-69C788B1-A194-47D2-A6D3-34946D9F2B76Q35628438-8A94E429-B721-4A58-8D1E-1DEC27BC29E0Q35738663-EBAB8491-05D1-4150-B82A-351C71DA599FQ36359339-91E2DD22-8A7E-49A6-8DD2-0A35A62A6CBDQ39151547-22A38426-C82F-47AF-82E4-A1AF6717A270Q40569399-97EBE1D9-17F1-45A3-8A07-F6CF5DA2349CQ42034826-063EA0F5-99B3-4B01-BAF3-7FB1895700C8Q42365306-C4D7B328-CBC5-4074-8A40-5F748376B71EQ44623571-84128F6D-65A5-4D0E-A3AA-04C1A49D3D54Q47147446-F371EBE5-C4A5-41A8-B970-3414CF60381B
P2860
Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Chromosome 3p allele loss in e ...... h clinicopathological features
@nl
Chromosome 3p allele loss in e ...... clinicopathological features.
@ast
Chromosome 3p allele loss in e ...... clinicopathological features.
@en
type
label
Chromosome 3p allele loss in e ...... h clinicopathological features
@nl
Chromosome 3p allele loss in e ...... clinicopathological features.
@ast
Chromosome 3p allele loss in e ...... clinicopathological features.
@en
prefLabel
Chromosome 3p allele loss in e ...... h clinicopathological features
@nl
Chromosome 3p allele loss in e ...... clinicopathological features.
@ast
Chromosome 3p allele loss in e ...... clinicopathological features.
@en
P2093
P2860
P356
P1476
Chromosome 3p allele loss in e ...... h clinicopathological features
@en
P2093
P2860
P304
P356
10.1136/MP.54.5.300
P407
P577
2001-10-01T00:00:00Z